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Chromatin modifying activities inherent to polycomb
repressive complexes PRC1 and PRC2 play an
essential role in gene regulation, cellular differentia-
tion, and development. However, the mechanisms
by which these complexes recognize their target
sites and function together to form repressive chro-
matin domains remain poorly understood. Recruit-
ment of PRC1 to target sites has been proposed to
occur through a hierarchical process, dependent
on prior nucleation of PRC2 and placement of
H3K27me3. Here, using a de novo targeting assay
in mouse embryonic stem cells we unexpectedly
discover that PRC1-dependent H2AK119ub1 leads
to recruitment of PRC2 and H3K27me3 to effectively
initiate a polycomb domain. This activity is restricted
to variant PRC1 complexes, and genetic ablation
experiments reveal that targeting of the variant
PCGF1/PRC1 complex by KDM2B to CpG islands is
required for normal polycomb domain formation
and mouse development. These observations pro-
vide a surprising PRC1-dependent logic for PRC2
occupancy at target sites in vivo.
INTRODUCTION
In eukaryotic cells, chromatin structure and posttranslational
modification of histone proteins play central roles in regulating
gene expression. This is exemplified in animals where polycomb
group proteins function as chromatin-based transcriptional re-
pressors through their capacity to catalyze histonemodifications
and form higher order chromatin structures (recently reviewed in
Schwartz and Pirrotta, 2013; Simon and Kingston, 2013). Loss ofpolycomb protein function in Drosophila leads to abnormal body
plan specification and in vertebrates polycomb orthologs are
essential for normal embryonic development. Polycomb proteins
are also perturbed in a range of cancers, suggesting that the
polycomb system is critical for maintenance of normal cell iden-
tity (Bracken and Helin, 2009).
Polycomb proteins are generally found in one of two protein
complexes, the polycomb repressive complexes 1 or 2 (PRC1
or PRC2). In mammals, the catalytic core of PRC2 is comprised
of EZH1 or EZH2, which trimethylate histone H3 on lysine 27
(H3K27me3) (Cao et al., 2002; Czermin et al., 2002; Kuzmichev
et al., 2002; Mu¨ller et al., 2002). A series of auxiliary proteins,
including SUZ12 and EED, associate with EZH1/2 and modulate
targeting, chromatin binding, and catalytic activity (Cao and
Zhang, 2004; Ketel et al., 2005; Margueron et al., 2009; Pasini
et al., 2004). In contrast, PRC1 monoubiquitylates histone H2A
on lysine 119 (H2AK119ub1) (de Napoles et al., 2004; Wang
et al., 2004a). The catalytic core of PRC1 consists of RING1A
or RING1B, which dimerize with one of six PCGFprotein partners
(PCGF1-6) that regulate assembly of specific PRC1 complexes
(Buchwald et al., 2006; Chamberlain et al., 2008; Farcas et al.,
2012; Gao et al., 2012; Gearhart et al., 2006; Li et al., 2006;
Ogawa et al., 2002; Sa´nchez et al., 2007). Together, the com-
bined activities of PRC1 and PRC2 are thought to be essential
for normal polycomb-mediated transcriptional repression and
developmental gene regulation (recently reviewed in Simon
and Kingston, 2013). Nevertheless, the molecular mechanisms
by which polycomb group proteins recognize their target
sites and initiate repressive chromatin domains remain poorly
defined.
Molecular and functional characterization of the polycomb
repressive complexes has revealed that they do not function
independently (Bracken et al., 2006; Ku et al., 2008; Papp and
Mu¨ller, 2006; Schwartz et al., 2006). Instead, H3K27me3 placed
by PRC2 is recognized by PRC1 complexes that contain chro-
mobox (CBX) proteins (Cao et al., 2002; Min et al., 2003; WangCell 157, 1445–1459, June 5, 2014 ª2014 The Authors 1445
et al., 2004b). Based on these initial observations, the prevailing
view over the past decade has been that PRC1 is recruited in a
hierarchical manner to sites with pre-existing PRC2 activity
and H3K27me3. However, it has recently emerged that CBX pro-
teins are in direct competition with two additional factors, RYBP/
YAF2, for a mutually exclusive binding site on RING1A/B (Wang
et al., 2010). Significantly, H3K27me3-binding CBX proteins are
limited to canonical PRC1 complexes containing either PCGF2
(MEL18) or PCGF4 (BMI1) and the Polyhomeotic proteins
(PHC1/2/3) (Gao et al., 2012; Levine et al., 2002), while all
PCGF proteins interact with RYBP/YAF2 to form variant PRC1
complexes lacking CBX proteins (Farcas et al., 2012; Gao
et al., 2012; Gearhart et al., 2006; Lagarou et al., 2008; Sa´nchez
et al., 2007; Tavares et al., 2012) (Figure 1A). The identification of
variant PRC1 complexes and the observation that RING1B can
occupy many of its target sites in the absence of H3K27me3
suggests that the hierarchical recruitment mechanism cannot
explain all PRC1 complex targeting (Schoeftner et al., 2006;
Tavares et al., 2012). Therefore, the central principles that under-
pin recognition of polycomb target sites in vivo and themolecular
chain of events that leads to the formation of polycomb domains
integrating both PRC1 and PRC2 activity remain unclear.
In this study, we utilize a de novo targeting system and
discover, contrary to expectation based on the proposed hierar-
chical recruitment mechanism, that binding of variant PRC1
complexes to chromatin is sufficient to initiate the formation of
a polycomb domain containing PRC2 and H3K27me3. This
activity is inherent to variant PRC1 complexes and relies on
H2AK119ub1. Building on this striking observation, genetic abla-
tion approaches in mouse embryonic stem cells (ESCs) reveal
that deletion of PRC1 has dramatic genome-wide effects on
PRC2 occupancy and H3K27me3. We further demonstrate that
recognition of nonmethylated DNA by KDM2B, part of the
PCGF1/PRC1 variant complex, is important for deposition of
H2AK119ub1 and recruitment of PRC2 to a subset of CpG island
targets and that this targeting activity is essential for normal
mouse development. Together, these observations reveal a
new PRC1-dependent logic for polycomb domain formation.
RESULTS
A System to Target PRC1 to Chromatin De Novo
The hierarchical recruitment model posits that PRC2-dependent
H3K27me3 is required to recruit canonical PRC1 complexes to
chromatin. The recent demonstration that variant PRC1 com-
plexes bind to many target sites, albeit at lower levels, indepen-
dently of H3K27me3 suggests that PRC1 function may be
more complex than previously envisaged (Tavares et al., 2012).
This new insight necessitates a more detailed examination of
mammalian PRC1 complex function and targeting in vivo. There-
fore, we sought to design a system in which individual PRC1
complexes could be targeted de novo to a chromatin environ-
ment free from the complexities and regulatory influences of
natural polycomb target sites. To achieve this, a large bacterial
artificial chromosome (BAC) containing human DNA that lacks
identifiable genes and shows no evidence for gene-, enhancer-,
or polycomb-associated chromatin modifications was selected
and bacterial Tet operator (TetO) DNA-binding sites were cen-1446 Cell 157, 1445–1459, June 5, 2014 ª2014 The Authorstrally inserted (Figure 1B). Importantly, the TetO lacks CpG
dinucleotides and has no resemblance to natural polycomb tar-
gets which are CpG-rich (Ku et al., 2008). The TetO BAC was
transposed into mouse ES cells at a site on chromosome 8,
effectively flanking the TetO array with long stretches of inert
chromatin (Figures 1B, S1A, and S1B). Fusion of PRC1 compo-
nents to the bacterial Tet repressor (TetR) DNA-binding domain
would permit de novo recruitment to the TetO array (Figure 1C)
and the direct consequences of fusion protein occupancy could
be examined by chromatin immunoprecipitation (ChIP).
Variant PRC1 Complexes Place H2AK119ub1 and
Recruit PRC2
In mammals, PCGF proteins (PCGF1-6) are thought to define the
composition of individual PRC1 complexes and regulate their
assembly and function (Figure 1A). To dissect how individual
PRC1 complexes function on chromatin, PCGF1-5 were fused
to TetR and stably expressed in the TetO cell line (Figure 1C).
ChIP experiments revealed that TetR-PCGF fusion proteins
bound the TetO array and diminished to background levels in
flanking regions (Figure 1D). All PCGF proteins resulted in
recruitment of RING1B, but surprisingly, only PCGF1, 3, and 5,
which exclusively form variant PRC1 complexes (Farcas et al.,
2012; Gao et al., 2012; Gearhart et al., 2006; Sa´nchez et al.,
2007), placed significant levels of H2AK119ub1 (Figure 1D).
PRC1 and PRC2 largely occupy a common set of target sites
in vivo (Ku et al., 2008; Papp and Mu¨ller, 2006; Schwartz et al.,
2006; Tolhuis et al., 2006), and this has been attributed to the
hierarchical recruitment mechanism. Therefore, the possibility
that PRC1 could potentially drive a reciprocal process and
mediate PRC2 occupancy has not been specifically examined.
By directly targeting individual PRC1 complexes to the TetO
array, a unique opportunity existed to test whether PRC1 com-
plexes can also drive PRC2 occupancy. Surprisingly, in the
TetR-PCGF1, 3, and 5 fusion lines, ChIP analysis revealed bind-
ing of PRC2 components and H3K27me3 in regions flanking the
TetO (Figure 1E). In contrast, TetR fusions with PCGF proteins
that can form canonical PRC1 complexes (PCGF2 and 4) re-
sulted in little, if any, PRC2 targeting and H3K27me3 (Figure 1E).
Strikingly, variant complex-dependent PRC2 recruitment and
H3K27me3 was also observed at a single naturally occurring
TetO site in the mouse genome (Figures S1C and S1D), indi-
cating that this is not unique to the engineered TetO array.
Therefore, contrary to expectation based on the hierarchical
recruitment mechanism, de novo recruitment of the PCGF 1, 3,
and 5 variant PRC1 complexes results in the formation of a
polycomb domain containing PRC2 and H3K27me3.
The Hierarchical PRC2-Dependent Recruitment of
Canonical PRC1 Complexes Fails to Place H2AK119ub1
Surprisingly, PCGF proteins that form canonical PRC1 com-
plexes appeared less competent at H2AK119ub1 placement in
tethering assays (Figure 1D). This lack of activity could be
inherent to canonical PRC1 complexes or possibly result from
their covalent fusion to TetR. To circumvent the necessity to
fuse canonical complexes to TetR, PRC2 was recruited to
the TetO via a TetR-EED fusion (Figure 2A) (Hansen et al.,
2008). This led to deposition of H3K27me3 and recruitment of
Figure 1. PCGF 1, 3, and 5 Variant PRC1 Complexes Catalyze H2AK119ub1 and Create A PolycombDomain Containing PRC2 and H3K27me3
(A) A schematic illustrating the core components of canonical and variant PRC1 complexes.
(B) The TetO array at its integration site on mouse chromosome 8.
(C) Targeting of factors to the TetO via the TetR DNA-binding domain. Numbers represent qPCR primer positions (kb) with respect to TetO array.
(D) ChIP analysis for fusion protein occupancy (TetR), RING1B, H2AK119ub1, and histone H3 across the TetO containing locus. Fusion protein identity is
indicated above each panel.
(E) As in (D) ChIP analysis for PRC2 components and H3K27me3. All ChIP experiments were performed at least in biological duplicate with error bars showing
standard error of the mean (SEM).
See also Figure S1.
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Figure 2. Hierarchical Recruitment of Canonical PRC1 Fails to
Result in H2AK119ub1
(A) ChIP analysis for fusion protein occupancy (TetR), PRC2 components, and
H3K27me3 across the TetO-containing locus in lines expressing TetR alone
and a TetR-EED fusion.
(B) ChIP analysis for PRC1 components and H2AK119ub1 performed as
described in (A).
1448 Cell 157, 1445–1459, June 5, 2014 ª2014 The Authorsendogenous PCGF2 and CBX7, but not PCGF1, suggesting
PRC2-dependent recruitment of canonical PRC1 complexes
(Figure 2B). As was the case with direct tethering of PCGF2 or
4, native canonical PRC1 complex nucleation failed to deposit
H2AK119ub1, suggesting the lack of activity in canonical
PRC1 tethering experiments does not result from TetR fusion
(Figure 2B). Interestingly, the binding profiles for canonical
PRC1 components were not completely coincident with
H3K27me3, as might be expected if occupancy was entirely
CBX dependent. It remains unclear why this disparity in profiles
existed, but it may result from secondary structural effects driven
by exclusive canonical PRC1 complex recruitment (Isono et al.,
2013) or other undefined mechanisms involved in canonical
PRC1 recruitment to regions containing PRC2 and H3K27me3.
Interestingly, a similar discordance between CBX (PC) protein
binding and H3K27me3 was observed at polycomb target sites
in Drosophila cell culture models (Schwartz et al., 2006). Never-
theless, this apparent failure of PRC2 and H3K27me3 to direct
H2AK119ub1 parallels observations in mouse ESC lines devoid
of H3K27me3 where levels of H2AK119ub1 at polycomb target
sites are largely unaffected (Schoeftner et al., 2006; Tavares
et al., 2012). Together, these observations strongly suggest
that PRC2-mediated recruitment of canonical PRC1 complexes
fails to catalyze significant levels of H2AK119ub1.
Deposition of H2AK119ub1 Is Sufficient to Nucleate
PRC2 and H3K27me3
The unexpected observation that variant PRC1 complexes can
nucleate PRC2 to establish a polycomb domain de novo sug-
gests that a feature associated with variant complex occupancy,
perhaps H2AK119ub1, is responsible for this activity (Figure 1).
To test this possibility, a single polypeptide fusion between the
dimerization domains of RING1B and PCGF4 was engineered
and fused to TetR (Bentley et al., 2011; Buchwald et al., 2006;
Li et al., 2006). This minimal RING1B/PCGF4 catalytic domain
(RPCD) does not form normal PRC1 complexes (Figure 3A) but
retains H2AK119ub1 E3 ligase activity (Figure 3B) (Cooper
et al., 2014) leading to a striking enrichment of EZH2, SUZ12,
and H3K27me3 at the TetO (Figure 3B). When mutations were
engineered in TetR-RPCD (TetR-RPCDmut), rendering it inca-
pable of catalyzing H2AK119ub1, PRC2 and H3K27me3 were
no longer recruited to the TetO (Figure 3B). This suggests that
H2AK119ub1, and not simply binding of PRC1 complexes, is
the central determinant driving PRC1-dependent recruitment
of PRC2.
Deletion of PRC1 and Loss of H2AK119ub1 Affects
PRC2 Occupancy and H3K27me3 Genome-wide
To examine the possibility that H2AK119ub1 may play a general
role in PRC2 localization and activity at normal polycomb target
sites, we exploited a Ring1a/Ring1bfl/fl mouse ESC system, in
which H2AK119ub1 can be rapidly depleted by removing the
catalytic core of all PRC1 complexes (RING1A/B) through addi-
tion of the drug tamoxifen, without disrupting the cellular proteinAll ChIP experiments in (A) and (B) were performed at least in biological
duplicate with error bars showing SEM.
Figure 3. H2AK119ub1 Is Required for PRC1-Dependent Recruit-
ment of PRC2 and H3K27me3
(A) Mass spectrometry analysis of purified TetR-PCGF4 and TetR-RPCD
(minimal RING1B/PCGF4 catalytic domain) proteins. The mascot score and
percentage coverage is indicated for polycomb group proteins in each sample.
(B) ChIP analysis for PRC1, PRC2 and their respective modifications in cell
lines expressing TetR, TetR-RPCD, and TetR-RPCDmut. All ChIP experiments
were performed at least in biological duplicate with error bars showing SEM.levels of PRC2 components (Endoh et al., 2008) (Figures 4A–4C).
Following RING1A/B deletion, ChIP-sequencing revealed a clear
loss of SUZ12, EZH2, and H3K27me3 at individual genes (Fig-
ures 4D and S2A) and at target sites genome-wide (Figure 4E
and 4F). Indeed, 85% of SUZ12 and 83% of EZH2 sites showed
a greater than 1.5-fold reduction in occupancy after PRC1
removal (Figures 4G and S3A). A closer inspection of SUZ12
sites defined as having a less than 1.5-fold change in PRC2, re-
vealed that these sites do exhibit an observable loss in PRC2
binding (Figure S3B, S3C, and S3D) suggesting that most
PRC2 sites are affected by loss of PRC1 activity. These effects
on PRC2 occupancy were seemingly independent of high-level
gene reactivation, as PRC2 reductions occurred at genes dis-
playing small or large fluctuations in gene expression (Figures
S2B and S2C).
Previous studies report that specific polycomb target sites rely
on transcription factors or long noncoding RNAs (lncRNAs) for
normal polycomb protein recruitment (Simon and Kingston,
2013). In mouse ESCs the transcription factor REST (Arnold
et al., 2013; Dietrich et al., 2012) and theMeg3 lncRNA (Kaneko
et al., 2014) are thought to contribute to these targeting events.
Interestingly, following PRC1 deletion, PRC2 occupancy was
reduced at REST-occupied PRC2 sites (Figure S3E) and Meg3
lncRNA targets (Figure S3F), suggesting these mechanisms are
insufficient to maintain normal levels of PRC2 and H3K27me3
in the absence of PRC1. Further segregation of PRC2 sites into
those existing in a ‘‘bivalent’’ state containing H3K4me3 and
H3K27me3 revealed that this subset of PRC2 sites had a slightly
larger fold change in PRC2 occupancy following PRC1 deletion
(Figure S3G). However, this difference was modest compared
to the overall magnitude of PRC2 loss observed at both bivalent
and nonbivalent sites.
Unfortunately, it was not possible to examine whether long-
term ablation of PRC1 activity would lead to a complete loss
of PRC2 occupancy on chromatin, because mouse ESCs
completely lacking PRC1 (Endoh et al., 2008), unlike those lack-
ing PRC2 (Boyer et al., 2006; Chamberlain et al., 2008; Leeb
et al., 2010; Pasqualucci et al., 2011), cannot be continuously
maintained in culture. Under the conditional deletion conditions
used here, some degree of residual PRC1 is evident (Figure 4D,
4E, and S2A), and this may contribute to the remaining
PRC2 occupancy. It should be noted, however, that PRC1-
independent PRC2 targeting activities could also contribute to
this residual PRC2 occupancy (Simon and Kingston, 2013)
(see Discussion). Nevertheless, to examine in more detail the
relationship between PRC1 loss and the resulting reduction in
PRC2 occupancy, the fold change in PRC1 and PRC2 was
compared at individual target sites genome-wide. This revealed
a striking genome-wide correlation between the magnitude of
PRC1 and PRC2 loss (Figures 4H and S3H), suggesting thatCell 157, 1445–1459, June 5, 2014 ª2014 The Authors 1449
Figure 4. PRC1 Has a Genome-wide Role in PRC2 Recruitment and Polycomb Domain Formation at Target Sites in Mouse ESCs
(A) A schematic of the Ring1a/Ring1bfl/fl system in which addition of tamoxifen (OHT) leads to deletion of RING1A/B.
(B) ChIP analysis for RING1B and H2AK119ub1 at polycomb target sites before (OHT) and after 48 hr (+OHT) tamoxifen treatment. ChIP experiments were
performed at least in biological duplicate with error bars showing SEM.
(C) Western blot analysis of polycomb factors following deletion of RING1A/B.
(legend continued on next page)
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PRC1 and H2AK119ub1 are central players in normal PRC2
nucleation.
KDM2B Recruits the Variant PCGF1/PRC1 Complex to
Create a PRC2-Containing Polycomb Domain
Deletion of RING1A/B inmouse ESCs supports amodel whereby
H2AK119ub1 contributes to the occupancy of PRC2 at natural
target sites in vivo. However, removal of RING1A/B disrupts
both canonical and variant PRC1 complex activity. Understand-
ing if variant PRC1 complexes can drive this process at natural
target sites is challenging, as variant PRC1 complex targeting
mechanisms remain poorly defined. An exception is the
PCGF1/PRC1 complex which contains a histone lysine deme-
thylase protein, KDM2B, which binds to nonmethylated DNA
via a ZF-CxxC DNA-binding domain (Farcas et al., 2012; He
et al., 2013; Long et al., 2013; Wu et al., 2013). Nonmethylated
DNA is generally concentrated in vertebrate regulatory elements
called CpG islands, and most mammalian polycomb target sites
are associated with CpG islands (Ku et al., 2008). KDM2B may
therefore represent a direct molecular link between recognition
of CpG island target sites and occupancy of both PRC1 and
PRC2. To determine if KDM2B binding is sufficient to recruit
the PCGF1/PRC1 complex and establish a polycomb domain
de novo, a TetR-KDM2B fusion protein was stably expressed
in the TetO cell line (Figure 5A). TetR-KDM2B led to RING1B,
PCGF1, and H2AK119ub1 deposition (Figure 5A). This was not
observed with the related KDM2A protein which does not
interact with PRC1 (Figure 5A) (Blackledge et al., 2010). Impor-
tantly, PCGF1/PRC1 recruitment by KDM2B resulted in binding
of PRC2 and H3K27me3 (Figures 5A and S4C). This activity
was dependent on recruitment of PCGF1/PRC1, as depletion
of PCGF1 in the TetR-KDM2B line caused a clear reduction in
both PRC1 and PRC2 (Figures 5B and 5C). Interestingly, poly-
comb domain formation did not rely on KDM2B demethylase
activity, as a catalytic mutant of KDM2B or a short form of the
protein that lacks the demethylase domain recruited PRC1 and
PRC2 to similar levels (Figures S4A–S4C). Therefore, de novo
targeting of the PCGF1/PRC1 complex by KDM2B leads to poly-
comb domain formation in a manner similar to TetR-PCGF1
(Figure 1).
A System to Inducibly Ablate Targeting of the Variant
PCGF1/PRC1 Complex by KDM2B
The observation that KDM2B can nucleate PRC1 and PRC2
provided an opportunity to examine whether targeting of the
PCGF1/PRC1 variant complex to natural CpG island target sites
is important for polycomb domain formation. To achieve this, a
novel genetic system was designed in which an exon that(D) Snapshots of ChIP-seq traces for RING1B, SUZ12, EZH2, and H3K27me3 in th
at the Grik3 and Tmem163 genes. Bio-CAP indicates nonmethylated DNA and C
(E) Heat map analysis of SUZ12 peaks (n = 3,819), showing ChIP-seq data for RIN
peaks prior to (OHT) and after 48 hr +OHT treatment. Bio-CAP is included to in
(F) A box and whisker plot showing log2 fold changes in normalized read count
treatment.
(G) A Venn diagram showing the overlap of RING1B (light blue) and SUZ12 (light gr
greater than 1.5-fold change in SUZ12 occupancy (DSUZ12, dark green) after 48
(H) A scatter plot comparing the fold change of RING1B and SUZ12 at SUZ12 p
See also Figures S2 and S3.encodes most of the KDM2B ZF-CxxC domain and is shared
by both the long and short form of the protein (Figures S4 and
S5A) (Fukuda et al., 2011) was flanked by loxP sites (Kdm2bfl/fl)
(Figure 5D). Homozygous Kdm2bfl/fl mouse ESC lines were
then derived that also stably express a tamoxifen-inducible
form of Cre-recombinase. Addition of tamoxifen rapidly yielded
KDM2B long and short form proteins that lack the ZF-CxxC
domain (Figures 5E and S5B), but remain associated with the
PCGF1/PRC1 variant complex (Figure S5D). Importantly, cellular
levels of PRC1 and PRC2 components were unaffected (Fig-
ure S5C). ChIP-seq for KDM2B in the Kdm2bfl/fl cells revealed
KDM2B occupancy at CpG islands as previously described (Fig-
ure 5F) (Farcas et al., 2012; He et al., 2013; Wu et al., 2013).
However, tamoxifen-mediated deletion of the ZF-CxxC domain
caused a near complete loss of KDM2B chromatin occupancy
and removal of PCGF1 from CpG islands (Figures 5F and 5G).
Therefore, deletion of the KDM2B ZF-CxxC domain is sufficient
to ablate normal targeting of the PCGF1/PRC1 complex in vivo.
KDM2B-Mediated PCGF1/PRC1 Targeting Is Required
for Normal Recruitment of PRC2 and Polycomb Domain
Formation at a Subset of CpG Island Sites
To identify polycomb sites that are dependent on KDM2B-medi-
ated targeting for RING1B binding, RING1B ChIP-seq was car-
ried out in the Kdm2bfl/fl and tamoxifen treated cells. Removal
of the KDM2B ZF-CxxC domain resulted in a widespread reduc-
tion of RING1B chromatin binding (Figures 6A–6D). Of the 3,488
high-confidence RING1B peaks identified in ESCs, 43% showed
a greater than 1.5-fold reduction in RING1B occupancy after
tamoxifen treatment (Figure 6D), suggesting that a subset of
RING1B-bound CpG islands is most sensitive to KDM2B loss,
and other PRC1 complexes must contribute to RING1B occu-
pancy at the remaining sites. Importantly, sites exhibiting
RING1B loss also showed reduced H2AK119ub1 levels, consis-
tent with a role for PCGF1/PRC1 in catalyzing this modification
(Figure 6I).
When SUZ12 ChIP-seq was carried out in the Kdm2bfl/fl and
tamoxifen treated cells, there was a striking reduction of
SUZ12 occupancy which broadly corresponded to the reduction
in RING1B (Figures 6A–6D). Indeed, 84% of SUZ12 peaks
showing a greater than 1.5-fold reduction in SUZ12 binding
overlapped with RING1B peaks (Figure 6D), and 78% of these
regions were associated with a greater than 1.5-fold reduction
in RING1B binding. This again suggests an intimate relation-
ship between loss of KDM2B-mediated PCGF1/PRC1 targeting
and PRC2 occupancy. To examine this more closely, the
relative change in the levels of RING1B and SUZ12 were
directly compared (Figures 6E and 6F). Strikingly, as with theeRing1a/Ring1bfl/fl cells prior to (OHT) and following 48 hr +OHT treatment
pG islands (CGI) are shown as green bars.
G1B, SUZ12, EZH2, and H3K27me3 at a 10 kb region centered over the SUZ12
dicate nonmethylated DNA at these sites.
s comparing the ChIP-seq signal at SUZ12 sites OHT and after 48 hr +OHT
een) peaks including a further segregation of SUZ12-bound regions that show a
hr tamoxifen treatment (+OHT).
eaks OHT and after 48 hr +OHT treatment.
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Ring1a/Ring1bfl/fl system, the magnitude of RING1B and
SUZ12 loss correlated well (Figure 6F), suggesting a direct rela-
tionship between PRC1 and PRC2 occupancy. Sites showing
PRC2 loss also showed lower H3K27me3 levels (Figure 6I) and
reduced binding of the canonical PRC1 complex component
PCGF2 (Figure 6I). Interestingly, following loss of PCGF1/PRC1
targeting, genes with decreased RING1B occupancy exhibited
only a very modest upregulation of average gene expression
when analyzed by RNA-seq (Figures 6C and 6G), and the magni-
tude of RING1B loss and gene expression change showed little
correlation (Figures 6H, 6I, and 6J). This supports a model
whereby direct targeting of PRC1 to target sites in vivo contrib-
utes to the occupancy of PRC2, independently of large changes
in gene expression.
Disruption of PCGF1/PRC1 Targeting Leads to Axial
Skeletal Transformations and Embryonic Lethality
in Mice
Perturbation of Ring1a or Ring1b in mice causes axial skeletal
transformations (del Mar Lorente et al., 2000; Suzuki et al.,
2002) due to defects in Hox gene expression, while deletion of
Ring1b alone or both Ring1a and Ring1b leads to embryonic
lethality (Posfai et al., 2012; Voncken et al., 2003). To understand
how PCGF1/PRC1 targeting affects development, mice hemizy-
gous for loss of the KDM2B ZF-CxxC domain were generated by
crossing Kdm2bfl/fl mice to a mouse constitutively expressing
Cre-recombinase. Initial observations suggested that loss of
the KDM2B ZF-CxxC domain was semi-lethal as few heterozy-
gous mice were recovered. When Kdm2bwt/DCxxC were mated
to wild-type mice only 20% of offspring at 10 days postnatal
(dpn) were Kdm2bwt/DCxxC, suggesting partial haploinsufficiency
(Figure 7A). To examine if the Kdm2bwt/DCxxC mice exhibited
homeotic transformations, skeletal preparations from newborn
(n = 10) and 11 dpn (n = 2) Kdm2bwt/DCxxC mice were compared
to control Kdm2bwt/wt mice. All of the Kdm2bwt/DCxxC heterozy-
gous animals exhibited skeletal alterations with homeotic trans-
formations in cervical to sacral regions (Figures 7B and 7C).
Notably, seven of the ten newborn and both of the 11 dpn
Kdm2bwt/DCxxC mice had extra bony elements at vertebrae C7,
suggesting partial transformation into T1 (Kondo and Duboule,
1999). While the second thoracic vertebra (T2) usually has a
dorsal process, two of the newborn heterozygotes showed a
dorsal process at T1 suggesting T1 to T2 transformation.
Furthermore, dorsal processes were absent from T2 in six
newborn and both 11 dpn heterozygotes, suggesting transfor-
mation of T2 to T3. Finally, two of the newborn heterozygotesFigure 5. KDM2B Targets the PCGF1/PRC1 Variant Complex Leading
Novel System to Ablate KDM2B-Mediated Targeting of PCGF1/PRC1 t
(A) ChIP analysis for TetR, RING1B, PCGF1, H2AK119ub1, EZH2, and H3K27me3
TetR-KDM2A. ChIP experiments were performed at least in biological duplicate
(B) Western blot analysis of PRC1 and PRC2 protein levels after knockdown of P
(C) ChIP analysis for TetR, PCGF1, RING1B, and EZH2 following PCGF1 knockdo
biological duplicate with error bars showing SEM.
(D) A schematic illustrating tamoxifen (OHT)-dependent removal of the ZF-CxxC
(E) Western blot analysis of the Kdm2bfl/fl cell line following an OHT treatment tim
(F) A heat map covering a 10 kb region centered over CpG islands showing KDM2
(G) ChIP analysis of KDM2B and PCGF1 at gene-associated CpG islands and ge
error bars showing SEM. See also Figures S4 and S5.showed L6-S1 transformations. Together, these homeotic phe-
notypes indicate posterior transformation of the vertebral col-
umn and phenocopy classical polycomb mutations (Akasaka
et al., 1996; van der Lugt et al., 1994).
Attempts to generate Kdm2bDCxxC/DCxxC mice yielded no
viable offspring. An initial examination of the embryonic defects
in Kdm2bDCxxC/DCxxC embryos at 9 days postcoitum (dpc) sug-
gested that development ceased at around 7 to 8 dpc in five of
the embryos and two further embryos were composed only of
extraembryonic tissues (Figure 7D). These phenotypes are
much more severe than those previously reported for a Kdm2b
mutant mouse (Fukuda et al., 2011). However, in this previous
study, only the long form of KDM2B was disrupted, while the
short form of KDM2B, which can still target the PCGF1/PRC1
complex (Figure S4) was unperturbed. Therefore, complete abla-
tion of PCGF1/PRC1 targeting by removal of the ZF-CxxC
domain from both KDM2B isoforms reveals that this activity is
essential for normal development.
DISCUSSION
The co-occupancy of polycomb group proteins at target sites
has largely been viewed in the context of a hierarchical recruit-
ment model (Cao et al., 2002; Wang et al., 2004b). Although
this mechanism is clearly relevant for RING1B accumulation
on chromatin, the singularity of the hierarchical recruitment
pathway has recently been challenged by a series of observa-
tions in mammals demonstrating that PRC1 occupancy and
H2AK119ub1 can be achieved in the absence of PRC2 (Pasini
et al., 2007; Schoeftner et al., 2006; Tavares et al., 2012) and
observations in Drosophila suggesting that H3K27me3 is not
sufficient to recruit PRC1 complexes (Schwartz et al., 2006).
We now unexpectedly discover that variant, but not canonical,
PRC1 complex occupancy leads to binding of PRC2 and place-
ment of H3K27me3 in an H2AK119ub1-dependent manner, with
deletion of the catalytic core of PRC1 in mouse ESCs resulting
in a dramatic reduction in PRC2 and H3K27me3 at target
sites. Furthermore, KDM2B-mediated targeting of the variant
PCGF1/PRC1 complex to CpG islands is required for normal
PRC2 levels at a subset of target sites and failure to target
PCGF1/PRC1 results in polycomb phenotypes and embryonic
lethality in mice. This provides an alternative to the hierarchical
recruitment mechanism, effectively demonstrating that PRC1
complexes are not simply subservient readers of PRC2 activity
but can instead be actively recruited to target sites and act as
central players in polycomb domain formation.to PRC2 Recruitment and Formation of a Polycomb Domain and a
o Chromatin
across the TetO containing locus in lines expressing TetR, TetR-KDM2B, and
with error bars showing SEM.
CGF1 in the TetR-KDM2B fusion line.
wn in the TetR-KDM2B fusion line. ChIP experiments were performed at least in
domain from both KDM2B isoforms.
e course. (*) is a nonspecific cross reactive band.
B ChIP-seq in the Kdm2bfl/fl cells prior to () and after 72 hr (+) OHT treatment.
ne body regions. ChIP experiments were performed in biological triplicate with
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H2AK119ub1 levels are unaffected in ESCs lacking PRC2
(Schoeftner et al., 2006; Tavares et al., 2012) and disruption of
canonical PRC1-complex-specific subunits in Drosophila cell
culture does not significantly affect H2A ubiquitylation (Lagarou
et al., 2008). This is consistent with the failure of canonical
PRC1 complexes to placeH2AK119ub1 in tethering experiments
(Figure 1). Therefore, despite their competence to catalyze
H2AK119ub1 in vitro (Gao et al., 2012; Tavares et al., 2012),
canonical complexes do not seem to play a major role in
H2AK119ub1 deposition in vivo. This apparent discrepancy
may result from a subunit specific to canonical PRC1 complexes
that limits RING1A/B E3 ligase activity in cells, as a minimal cat-
alytic fusion of PCGF4 and RING1B that does not interact with
other canonical PRC1 complex proteins was competent to
catalyze H2AK119ub1 (Figure 3), whereas the intact canonical
PCGF4/PRC1 complex appeared largely inactive (Figure 1). A
candidate for this inhibitory activity may be the vertebrate poly-
homeotic orthologs (PHC1/2/3), which are specific to canonical
PRC1 complexes. PHC proteins have been shown to self-asso-
ciate via their sterile alpha motif (SAM) to organize polycomb
domains in vivo (Isono et al., 2013; Kim et al., 2002). It is tempting
to speculate that the hierarchical recruitment pathway may
largely function to drive PHC proteins to sites that have already
acquired a polycomb domain and impose further alterations in
chromatin structure.
The unexpected discovery that H2AK119ub1 plays a critical
role in PRC2 occupancy and H3K27me3 at target sites appears
at oddswith observations inmouse ESCs lacking RING1Bwhere
PRC2 function appeared less affected (Eskeland et al., 2010;
Leeb et al., 2010; van der Stoop et al., 2008). However, RING1B
null cells express RING1A and retain significant levels of
H2AK119ub1 (Eskeland et al., 2010), suggesting that the relative
level of H2AK119ub1 may be important for PRC2 occupancy.
Importantly, PRC1 activity appears to drive PRC2 occupancy
in other nonstereotypical examples of polycomb domain forma-
tion, suggesting this activity is not limited by genomic location
(Cooper et al., 2014). A future challenge remains to understand
the molecular determinants that link H2AK119ub1 and PRC2
binding.
It is a commonly held view that mammalian polycomb pro-
teins, under the guidance of site-specific DNA binding transcrip-Figure 6. Failure to Target the PCGF1/PRC1 Complex Leads to a Loss
(A) Snapshots of ChIP-seq traces for KDM2B, RING1B, and SUZ12 in the Kdm2
Epha7 and Klrg2 genes.
(B) Heat map analysis of RING1B peaks (n = 3,488), showing ChIP-seq data for KD
peak OHT and after 72 hr +OHT.
(C) Log2 fold changes in normalized read counts comparing the ChIP-seq and R
(D) A Venn diagram showing all RING1B peaks (light blue), intersectedwith RING1
occupancy after 72 hr +OHT treatment (DRING1B [dark blue] and DSUZ12 [gree
(E) A box and whisker plot indicating the log2 fold change in RING1B and SU
(DRING1B) or less than 1.5-fold (No Change) following 72 hr +OHT treatment. Th
above the plot.
(F) A scatter plot comparing the log2 fold change of RING1B and SUZ12 at RING
(G) A box and whisker plot indicating log2 fold change in gene expression at site
(H) A scatter plot comparing the log2 fold change of gene expression to the fold
(I) ChIP analysis for polycomb factors and modifications at regions showing loss
experiments were performed in biological triplicate with error bars showing SEM
(J) Gene expression analysis for the target genes analyzed by ChIP in (I). RT-PCtion factors or lncRNAs, are targeted to specific genes where
they direct transcriptional repression (discussed in Simon and
Kingston, 2013). In stark contrast to site-specific targeting fac-
tors, KDM2B binds broadly to promoter-associated CpG islands
through its nonmethylated DNA-binding activity, occupying
genes covering the complete expression spectrum (Farcas
et al., 2012; He et al., 2013; Wu et al., 2013). Given the capacity
of KDM2B to bind CpG islands, target the PCGF1/PRC1 variant
complex, and initiate polycomb domains de novo, it is surprising
that only a subset of the most repressed CpG island-associated
genes accumulate polycomb proteins. A possible explanation
for this somewhat paradoxical observation could be that coun-
teracting chromatin features associated with transcription are
sufficient to inhibit polycomb protein activity and that KDM2B/
PCGF1/PRC1 occupancy functions mainly as a sampling
module to identify sites that lack transcription and facilitate initi-
ation of a polycomb domain (Klose et al., 2013; Ku et al., 2008;
Lynch et al., 2012; Voigt et al., 2013). Viewed in this context,
one would predict that polycomb domain formation would not
directly drive gene repression, but may instead function to limit
stochastic or inappropriate reactivation of genes that have
already been transcriptionally silenced. Consistent with these
ideas, it was recently demonstrated through an elegant set of
kinetic experiments in mammalian cell culture systems that
polycomb chromatin modifications are mainly acquired at target
sites after transcriptional silencing has been achieved (Hoso-
gane et al., 2013; Yuan et al., 2012). This agrees with the more
general observation that loss of polycomb proteins in ESCs
leads to reactivation of only a subset of all genes that are heavily
occupied by polycomb proteins (Leeb et al., 2010). In agreement
with these general principles, loss of PCGF1/PRC1 targeting and
its capacity to form polycomb domains did not lead to extensive
gene reactivation (Figure 6).
It is clear that variant PRC1 complexes can drive de novo
PRC2 occupancy (Figure 1), and PRC1 is required for normal
polycomb domain formation (Figure 4). A variant PRC1 com-
plex-driven sampling model could provide a simple and flexible
solution for polycomb domain initiation and formation, but it
should be made clear that our observations do not exclude
potential contributions from PRC1-independent PRC2 targeting
events. Following PRC1 deletion, there was a reduction, butof H2AK119ub1, PRC2, and H3K27me3
bfl/fl cells prior to (OHT) and after 72 hr (+OHT) of tamoxifen treatment at the
M2B, RING1B, and SUZ12 covering a 10 kb region centered over the RING1B
NA-seq signal OHT and after 72 hr +OHT.
B or SUZ12 peaks that have a greater than 1.5-fold reduction in RING1B/SUZ12
n]).
Z12 occupancy at sites that have RING1B changes of greater than 1.5-fold
e significance of the changes in SUZ12 occupancy at these sites is indicated
1B sites in the Kdm2bfl/fl cells OHT and after 72 hr +OHT.
s described in (E).
change in RING1B occupancy at sites that show RING1B alterations.
of RING1B, no significant loss of RING1B, and a nontarget site (NTS). All ChIP
.
R was performed in biological triplicate. Error bars show SEM.
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Figure 7. Failure to Target PCGF1/PRC1 Results in Homeotic Phenotypes and Embryonic Lethality
(A) Kdm2bwt/DCxxC mice were mated with wild-type mice and at 11 day postnatal (dpn) offspring were genotyped. Results are summarized in a table.
(B) A schematic summarizing the homeotic phenotypes observed in newborn Kdm2bwt/DCxxC mice (n = 10) with the normal wild-type vertebrae organization
shown for comparison. The numbers in parentheses indicate the frequency of individual transformations.
(C) Examples of the vertebral column in wild-type and Kdm2bwt/DCxxC mice showing homeotic phenotypes. Top: 11 dpn heterozygotes that have additional
ossification at the C7 position indicating partial posteriorization (white triangles). Center: comparison of newborn wild-type and newborn Kdm2bwt/DCxxC mice
missing dorsal processes or that have the position of the process repositioned to the anterior (black arrowhead). Bottom: 6th lumbar vertebral column trans-
formed to sacrum in Kdm2bwt/DCxxC mice (red arrowhead).
(D) Kdm2b homozygous null embryos recovered at 9 dpc exhibited severe developmental delay (n = 5) or in some cases only extraembryonic development
(n = 2) (representative examples are shown in center and right, respectively). A heterozygote sibling is shown to indicate expected development at this stage
(left).not a complete loss, of PRC2 and H3K27me3 (Figure 4). While
residual PRC1 binding or epigenetic maintenance of pre-
existing PRC2 could be responsible for this, previously re-
ported PRC1-independent targeting mechanisms could also
play a central role in remaining PRC2 occupancy (Simon and
Kingston, 2013). Viewed in this light, it remains possible that1456 Cell 157, 1445–1459, June 5, 2014 ª2014 The AuthorsPRC1 and PRC2 are recruited to target sites independently
and then function to mutually sustain and stabilize their respec-
tive binding. A better understanding of the molecular mecha-
nisms that underpin polycomb protein targeting will help to
further define the relationship between PRC1 and PRC2 on
chromatin.
Cancer-exome-sequencing endeavours have recently re-
vealed that core components of the KDM2B/PRC1 complex,
including KDM2B itself and BCOR/L1, are frequently mutated
in a range of cancers, particularly leukemias (Brookes et al.,
2012; Grossmann et al., 2011; Pasqualucci et al., 2011; Zhang
et al., 2012). Given the essential nature of polycombprotein func-
tion in vertebrate development and its implication in human
pathology, our fundamental discovery that PRC1 activity plays
an important role in normal PRC2 occupancy provides an unex-
pected new perspective on the principles that underpin poly-
comb domain formation. Furthermore, toward addressing the
central yet poorly understood question of defining how poly-
comb sites are established in vivo, we provide evidence that,
at least in some cases, there may exist a relatively simple molec-
ular chain of events whereby KDM2B-mediated recognition of
nonmethylated DNA at receptive CpG islands leads to recruit-
ment of PRC1 and deposition of H2AK119ub1 that ultimately
translates into occupancy of PRC2 necessary for normal place-
ment of H3K27me3.
EXPERIMENTAL PROCEDURES
Generation of the De Novo Targeting System
A TetO array comprising 14 TetO sites interspersed by randomCpG-free 21 bp
sequences was seamlessly recombineered into BAC RP11 419E6. Tol2
sequence elements were then recombineered into the plasmid backbone
portion of the BAC, together with a neomycin resistance cassette. Using
Lipofectamine 2000 (Life Technologies) the TetO BAC was cotransfected
with a Tol2 transposase expression plasmid into E14 mouse ESCs, and stable
G418 (400 mg/ml) resistant clones were obtained. A PCR screen was used to
identify a clone exhibiting Tol2-mediated integration and splinkerette PCR
was used to map the precise BAC integration site on mouse chromosome 8.
The TetR coding sequence was inserted into a modified pCAG-IRES-Puro
mammalian expression plasmid, between the coding sequence for anN-termi-
nal FLAG STREPx2 (FS2) tag and a 30 ligation-independent cloning (LIC) site.
The resultant plasmid was named pCAGFS2TetR. Coding sequences for pro-
teins of interest were inserted into pCAGFS2TetR by LIC cloning. All plasmids
were transfected into the TetO BAC-containing ESCs and stable clones ex-
pressing TetR fusion proteins were obtained by selection with puromycin
(1 mg/ml). TetR fusion proteins were detected in ChIP experiments using
an FS2-specific antibody. Other details of the TetR targeting system are
described in Extended Experimental Procedures.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Farcas et al., 2012), with minor
modifications. Briefly, for nonhistone ChIP cells were fixed for 1 hr in 2 mM
EGS, followed by 15 min in 1% formaldehyde, while for histone modification
ChIP cells were fixed for 10 min in 1% formaldehyde alone.
Cells were sequentially lysed and sonication was performed to produce
fragments of approximately 0.5–1 kb. Immunoprecipitation was performed
overnight at 4C with approximately 3 mg of antibody. Antibody-bound chro-
matin was isolated on protein A beads, washed extensively and purified as
described in Extended Experimental Procedures.
Gene Expression Analysis
For RNA-seq analysis, polyA+ RNA was purified from total RNA and then a
directional library was prepared using the NEBNext Ultra Directional RNA
library Prep Kit for Illumina (NEB, Ipswich, MA).
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